Publication: Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1′-biphenyl]-4-sulfonate derived thiosemicarbazones
| dc.contributor.author | Rafiq A. | |
| dc.contributor.author | Tayyab M. | |
| dc.contributor.author | Mali S. N. | |
| dc.contributor.author | Taslimi P. | |
| dc.contributor.author | Jawarkar R. D. | |
| dc.contributor.author | Gurav S. S. | |
| dc.contributor.author | Zhao X. | |
| dc.contributor.author | Sadeghian N. | |
| dc.contributor.author | Çakır F. | |
| dc.contributor.author | Shafiq Z. | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2025-08-21T21:50:19Z | |
| dc.date.issued | 2025-09-01 | |
| dc.identifier.citation | Rafiq A., Tayyab M., Mali S. N., Taslimi P., Jawarkar R. D., Gurav S. S., Zhao X., Sadeghian N., Çakır F., Shafiq Z., et al., "Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1′-biphenyl]-4-sulfonate derived thiosemicarbazones", BIOORGANIC CHEMISTRY, cilt.164, sa.108836, ss.1-16, 2025 | |
| dc.identifier.doi | 10.1016/j.bioorg.2025.108836 | |
| dc.identifier.issn | 0045-2068 | |
| dc.identifier.issue | 108836 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0045206825007163 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12645/41104 | |
| dc.identifier.volume | 164 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Eczacılık | |
| dc.subject | Meslek Bilimleri | |
| dc.subject | Farmasötik Kimya | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Pharmacology and Therapeutics | |
| dc.subject | Professional Sciences | |
| dc.subject | Pharmaceutical Chemistry | |
| dc.subject | Health Sciences | |
| dc.subject | Klinik Tıp (Med) | |
| dc.subject | Yaşam Bilimleri (Life) | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Farmakoloji ve Eczacılık | |
| dc.subject | Clinical Medicine (Med) | |
| dc.subject | Life Sciences (Life) | |
| dc.subject | Pharmacology & Toxicology | |
| dc.subject | Pharmacology & Pharmacy | |
| dc.subject | Farmakoloji | |
| dc.subject | Farmakoloji, Toksikoloji ve Eczacılık (çeşitli) | |
| dc.subject | Genel Farmakoloji, Toksikoloji ve Eczacılık | |
| dc.subject | Farmakoloji (tıbbi) | |
| dc.subject | İlaç Rehberleri | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Pharmacy | |
| dc.subject | Pharmacology | |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
| dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
| dc.subject | Pharmacology (medical) | |
| dc.subject | Drug Guides | |
| dc.subject | Life Sciences | |
| dc.title | Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1′-biphenyl]-4-sulfonate derived thiosemicarbazones | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.avesis.id | 627e07ff-557d-4b95-9601-10c5a3f3c38b |